Background: Alpha 2 macroglobulin (A2M; also known as ovostatin), a homotetrameric protein with four disulfidelinked subunits, has the unique feature of inactivating/inhibiting most known proteases including serine-, threonine-, cysteine-, aspartic-and metalloproteases. In chickens, A2M has been identified and characterized biochemically, but little is known of its functional role(s) in the oviduct, hormonal regulation of expression or its expression in ovarian carcinomas in chickens. Therefore, we investigated estrogen regulation of A2M gene expression during development of the chicken oviduct, and its expression in normal and cancerous ovaries from chickens.
Background
The alpha 2 macroglobulins (A2M) are proteins in blood that act as protease inhibitors in mammals [1] [2] [3] [4] . In humans, the A2M gene is a single-copy gene located on chromosome 12p12-13 that encodes for a functional homotetramer protein with disulfide-linked 180-kDa subunits [5, 6] . Even though A2M is produced predominantly by the liver, it may also be expressed in the reproductive tract, heart, and brain, and may have important roles in many physiological processes and medical illnesses including Alzheimer's disease [4, 7, 8] .
Of particular note, A2M increase in blood serum of women with inflammatory and neoplastic lesions of the ovary [9] . It also stimulates production of activin and inhibin in pre-ovulatory follicles [10, 11] and controls coordinate changes in uterine vasculature during pregnancy [4] . In addition, Umans et al. reported that A2m-deficient mice were viable and produced normal size litters with normal sex ratios over three generations [8] . Moreover, A2M regulates the function of cortical granule proteases and other trypsin-like proteases activated in sea urchin eggs during fertilization [12] . In chickens, A2M is also known as an ovostatin or ovomacroglobulin. It is found in the oviduct and egg white, but not in other tissues or serum [13] and it has a strong anti-collagenase activity [14, 15] . However, little is known about regulation of its expression by steroid hormones in the oviduct or its expression in normal and cancerous ovaries.
As the primary female sex hormone, estrogen regulates reproductive behavior. It is responsible for proliferation and differentiation of several cell types associated with osteoporosis, diabetes, cardiovascular disease, and reproductive carcinomas [16] [17] [18] [19] [20] [21] . The chicken oviduct is well-known as an excellent research model for studies of organ development and hormonal responsiveness [16] . During development of the chicken oviduct, estrogen stimulates proliferation and cytodifferentiation of epithelial cells to tubular gland cells and expression of oviduct-specific genes [22, 23] . However, progesterone interferes with normal estrogen-mediated cytodifferentiation of tubular gland cells [24] [25] [26] [27] . Estrogen also affects calcium metabolism for eggshell formation and ovipositioning or egg laying [28, 29] . In addition, estrogen administration to sexually immature chicks stimulates growth of the oviduct by inducing cellular hyperplasia and hypertrophy [16, 30] . The mammalian oviduct undergoes diverse biological changes in response to sex steroids during the estrous cycle and early pregnancy as these actions are pivotal to establishing an optimal microenvironment for events ranging from gamete transport to early embryonic development [31] . To investigate the biological actions and signaling pathways of estrogen, the chicken is one of the best animal models [16] . Indeed, steroid hormones are involved in many physiological and developmental processes accompanying modification of tissue-specific and conditional control of gene expression and homeostasis [16, 32] . Although general effects of estrogen and progesterone on the reproductive tract of vertebrates are well documented, details of their interactions that affect cell signaling pathways in avian species are unclear.
The objectives of this study were to: 1) determine tissue-and cell-specific expression of the A2M gene in chickens; 2) determine whether estrogen regulates expression of A2M during oviductal development in chicks; and 3) compare expression of A2M in normal and cancerous ovaries from laying hens. Results of this study indicate that A2M is a novel estrogen-stimulated gene during development of the chicken oviduct and that it may be an initial candidate gene for further study of the development of epithelial ovarian cancer in hens.
Methods

Experimental animals and animal care and use
The experimental use of chickens for this study was approved by the Institute of Laboratory Animal Resources, Seoul National University (SNU-070823-5). White Leghorn (WL) chickens were subjected to standard management practices at the University Animal Farm, Seoul National University, Korea with respect to management of hens for reproduction, incubation of eggs and rearing of chicks, as well as standard operating protocols in our laboratory. All chickens had ad libitum access to feed and water.
Tissue samples Study one
Following euthanasia of mature WL hens, tissue samples were collected from brain, heart, liver, kidney, muscle, small intestine, gizzard, ovary, oviduct and testis of 1-to 2-year-old males (n = 3) and females (n = 3). Subsets of these samples were frozen or fixed in 4% paraformaldehyde for further analyses. Frozen tissue samples were cut into 5-to 7-mm pieces, frozen in liquid nitrogen vapor, and stored at -80°C. The other samples were cut into 10 mm pieces and fixed in fresh 4% paraformaldehyde in PBS (pH 7.4). After 24 h, fixed tissues were changed to 70% ethanol for 24 h and then dehydrated and embedded in Paraplast-Plus (Leica Microsystems, Wetzlar, Germany). Paraffin-embedded tissues were sectioned at 5 μm.
Study two
Female chicks were identified by PCR analysis using W chromosome-specific primer sets [33] . Treatment with DES and recovery of the oviduct were conducted as reported previously [34, 35] . Briefly, a 15 mg DES pellet was implanted subcutaneously in the abdominal region of 1-week-old female chicks for release of hormone for 20 days [34, 36, 37] . Five chicks in each group were euthanized using 60%-70% carbon dioxide. Subsets of these samples were frozen or fixed in 4% paraformaldehyde for further analyses. Frozen tissue samples were cut into 5-to 7-mm pieces and frozen in liquid nitrogen. The other samples were cut into 10-to 15-mm pieces and fixed in fresh 4% paraformaldehyde in PBS (pH 7.4). After 24 h, fixed tissues were changed to 70% ethanol for 24 h and then dehydrated and embedded in Paraplast-Plus (Leica Microsystems, Wetzlar, Germany). Paraffin-embedded tissues were sectioned at 5 μm.
Study three
In this study, a total of 136 chickens (88 chickens over 36 months of age and 48 chickens over 24 months of age), which had completely stopped laying eggs were euthanized for biopsy and cancerous (n = 10) ovaries were collected. As a control, normal (n = 5) ovaries were also collected from egg-laying hens. We examined tumor stage in 10 hens with cancerous ovaries based on characteristic features of chicken ovarian cancers [38] . In three hens, ovarian tumor cells were classified as Stage III as they had metastasized to the gastrointestinal tract and superficial surface of the liver with profuse ascites in the abdominal cavity. In five hens, the tumors had metastasized to distant organs such as liver parenchyma, lung, gastrointestinal tract and oviduct with profuse ascites, so these were classified at Stage IV tumors. The other two hens did not have tumors in any other organs; therefore, their ovarian tumors were classified as Stage I. Subsets of these samples were frozen or fixed in 4% paraformaldehyde for further analyses. Frozen tissue samples were cut into 5-to 7-mm pieces and frozen in liquid nitrogen. The other samples were cut into 10 mm pieces and fixed in 4% paraformaldehyde in PBS (pH 7.4). After 24 h, fixed tissues were changed to 70% ethanol for 24 h and then dehydrated and embedded in Paraplast-Plus (Leica Microsystems, Wetzlar, Germany). Paraffin-embedded tissues were sectioned at 5 μm and stained with hematoxylin and eosin. Epithelial ovarian cancers in chickens were classified based on their cellular subtypes and patterns of cellular differentiation with reference to ovarian malignant tumor types in humans [38] .
RNA isolation
Total cellular RNA was isolated from frozen tissues using Trizol reagent (Invitrogen, Carlsbad, CA) according to manufacturer's recommendations. The quantity and quality of total RNA was determined by spectrometry and denaturing agarose gel electrophoresis, respectively.
Sequence analysis
For pair-wise comparisons, the amino acid sequences of A2M genes from each species were aligned using Geneious Pro Version 5.04 [39] with default penalties for gap and the protein weight matrix of BLOSUM (Blocks Substitution Matrix).
Semiquantitative RT-PCR analysis
The level of expression of A2M mRNA in various organs from chickens, including the oviduct, was assessed using semi-quantitative RT-PCR as described previously [40] . The cDNA was synthesized from total cellular RNA (2 ug) using random hexamer (Invitrogen, Carlsbad, CA) and oligo (dT) primers and AccuPower ® RT PreMix (Bioneer, Daejeon, Korea). The cDNA was diluted (1:10) in sterile water before use in PCR. For A2M, the sense primer (5'-CTG GCT CAC TGC CTT TGT GT-3') and antisense primer (5'-CCG TCA ACT TCC TTT GCT GA-3') amplified a 405-bp product. For GAPDH (housekeeping gene; glyceraldehyde 3-phosphate dehydrogenase), the sense primer (5'-TGC CAA CCC CCA ATG TCT CTG TTG-3') and antisense primer (5'-TCC TTG GAT GCC ATG TGG ACC AT-3') amplified a 301-bp product. The primers, PCR amplification and verification of their sequences were conducted as described previously [40] . PCR amplification was conducted using approximately 60 ng cDNA as follows: (1) 95°C for 3 min; (2) 95°C for 20 sec, 61°C for 40 sec, and 72°C for 1 min for 35 cycles (A2M), 30 cycles (GAPDH); and (3) 72°C for 5 min. Then, equal amounts of reaction product were analyzed using a 1% agarose gel, and PCR products were visualized using ethidium bromide staining. The amount of DNA present was quantified by measuring the intensity of light emitted from correctly sized bands under ultraviolet light using a Gel Doc™ XR+ system with Image Lab™ software (Bio-Rad).
Quantitative RT-PCR analysis
Total RNA was extracted from each oviduct of control and DES-treated chicks using TRIzol (Invitrogen) and purified using an RNeasy Mini Kit (Qiagen). Complementary DNA was synthesized using AccuPower ® RT PreMix (Bioneer, Daejeon, Korea). Gene expression levels were measured using SYBR ® Green (Sigma, St. Louis, MO, USA) and a StepOnePlus™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The GAPDH gene was simultaneously analyzed as a control and used for normalization of data. Expression of each target gene and GAPDH was analyzed in triplicate. Using the standard curve method, we determined levels of expression of the examined genes using the standard curves and C T values, and normalized them based on GAPDH expression levels. The PCR conditions were 95°C for 3 min, followed by 40 cycles at 95°C for 20 sec, 60°C for 40 sec, and 72°C for 1 min using a melting curve program (increasing the temperature from 55°C to 95°C at 0.5°C per 10 sec) and continuous fluorescence measurement. The ROX dye (Invitrogen) was used as a negative control for measurements of fluorescence. Sequence-specific products were identified by generating a melting curve in which the C T value represented the cycle number at which a fluorescent signal was significantly greater than background, and relative gene expression was quantified using the 2 -ΔΔCT method [41] . For the control, the relative quantification of gene expression was normalized to the C T of the control oviduct.
In situ hybridization analysis
For hybridization probes, PCR products were generated from cDNA with the primers used for RT-PCR analysis.
The products were gel-extracted and cloned into pGEM-T vector (Promega). After verification of the sequences, plasmids containing gene sequences were amplified with T7-and SP6-specific primers (T7:5'-TGT AAT ACG ACT CAC TAT AGG G-3'; SP6:5'-CTA TTT AGG TGA CAC TAT AGA AT-3') then digoxigenin (DIG)-labeled RNA probes were transcribed using a DIG RNA labeling kit (Roche Applied Science, Indianapolis, IN). Tissues were collected and fixed in 4% paraformaldehyde. The tissues were embedded in paraffin and sectioned at 5 μm on APEStreated (silanized) slides. The sections were then deparaffinized in xylene and rehydrated to diethylpyrocarbonate (DEPC)-treated water through a graded series of alcohol. The sections were treated with 1% Triton X-100 in PBS for 20 min and washed two times in DEPC-treated PBS. After washing in DEPC-treated PBS, the sections were digested with 5 μg/ml Proteinase K (Sigma) in TE buffer (100 mM Tris-HCl, 50 mM EDTA, pH 8.0) at 37°C. After post-fixation in 4% paraformaldehyde, sections were incubated twice for 5 min each in DEPC-treated PBS and incubated in TEA buffer (0.1 M triethanolamine) containing 0.25% (v/v) acetic anhydride. The sections were incubated in a prehybridization mixture containing 50% formamide and 4× standard saline citrate (SSC) for at least 10 min at room temperature. After prehybridization, the sections were incubated with a hybridization mixture containing 40% formamide, 4× SSC, 10% dextran sulfate sodium salt, 10 mM DTT, 1 mg/ml yeast tRNA, 1 mg/ ml salmon sperm DNA, 0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.2 mg/ml RNase-free bovine serum albumin and denatured DIG-labeled cRNA probe for overnight at 42°C in a humidified chamber. After hybridization, sections were washed for 15 min in 2× SSC at 37°C, 15 min in 1× SSC at 37°C, 30 min in NTE buffer (10 mM Tris, 500 mM NaCl and 1 mM EDTA) at 37°C and 30 min in 0.1× SSC at 37°C. After blocking with 2% normal sheep serum (Santa Cruz Biotechnology, INC.), the sections were incubated overnight with sheep anti-DIG antibody conjugated to alkaline phosphatase (Roche). The signal was visualized by exposure to a solution containing 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate, 0.4 mM nitroblue tetrazolium, and 2 mM levamisole (Sigma).
Statistical analyses
Differences in the variance between control and DEStreated oviducts were analyzed by analysis of variance, and differences between means were subjected to Student's t test. The probability value of P < 0.05 was considered statistically significant. Excel (Microsoft, Redmond, WA, USA) was used for statistical analyses.
Results
Multiple sequence alignment, pairwise comparisons, and phylogenetic analysis
The chicken A2M gene was found in the genomic region spanning 35,791 bp on chromosome 1. The gene consists of 35 exons and the mRNA has 4,715 bp encoding a protein with 1,454 amino acid residues. The primary sequence of chicken A2M was compared to those of some mammalian species. In pairwise comparisons of chicken A2M with eight other vertebrate species, chicken A2M protein has moderate homology to mammalian A2M proteins (42.4-45.4%, Table 1 ). In particular, chicken A2M protein contains the highly conserved macroglobulin 1 (MG1) and MG2 domains, A2M family N-terminal region, and A2M receptor binding domain found in mammalian A2M proteins (Additional file 1, Supplemental Figure S1 ). In the phylogenetic tree generated from primary sequences of available vertebrate A2M proteins, chicken A2M was placed between mammalian and amphibian species consistent with the general pattern of molecular evolution in vertebrates (Additional file 2, Supplemental Figure S2 ).
A2M mRNA expression in chickens (study one)
To determine tissue-specific expression of A2M mRNA in chickens, we collected various organs from male and female chickens and performed RT-PCR analysis. As shown in Figure 1 , A2M mRNA is abundantly expressed in the oviduct and, to a lesser extent, in the brain of female chickens. However, specific expression was not detected in any other organs analyzed for either sex. Therefore, further studies focused on A2M in the chicken oviduct.
Localization of A2M mRNA expression in the chicken oviduct
The oviduct of egg-laying hens includes the infundibulum (site of fertilization), magnum (production of components of egg-white), isthmus (formation of the soft shell membrane), and shell gland (formation of the egg shell). Using RT-PCR analysis, it was determined that A2M mRNA is expressed abundantly in the infundibulum, magnum, and isthmus of the chicken oviduct (Figure 2A ). At a lower abundance, A2M mRNA is also expressed in the shell gland. In addition, in situ hybridization analysis revealed that A2M mRNA is most abundant in glandular epithelium (GE) of the magnum but expressed to a lesser extent in GE of the isthmus and luminal epithelium (LE) and GE of the shell gland (Figure 2B) . Little or no mRNA was detected in stromal cells, blood vessels, immune cells or myometrium (smooth muscle) of the oviduct.
Effects of DES on A2M mRNA expression in the chicken oviduct (study two)
Oviduct-specific and cell-type specific expression of A2M in the oviductal segments of hens suggested regulation by estrogen during development of the oviduct in chicks. We reported that DES induces development and differentiation of the chicken oviduct [35] and discovered candidate genes regulating oviduct development in chickens [30] . Therefore, we examined A2M gene expression in the oviduct of 37-day-old chicks that received a subcutaneous implant of 15 mg DES in the abdominal region for 20 days [35] . We performed RT-PCR analyses using cDNAs from control-(n = 5) and DES-treated oviducts (n = 5), and then each segment of oviducts from DEStreated chicks ( Figure 3A and -3B ). In addition, as illustrated in Figure 3C , qPCR analysis revealed that DES stimulated a 22-fold increase (P < 0.001) in A2M mRNA in oviducts as compared to oviducts from control chicks. DES treatment also stimulated a 123-fold increase (P < 0.001) in A2M mRNA in the magnum ( Figure 3D ).
Further, in situ hybridization analyses revealed abundant expression of A2M mRNA only in GE of the isthmus and a lower abundance in GE of the magnum of chick oviducts treated with DES ( Figure 4 ). Cross-sections of the infundibulum, magnum, isthmus and shell gland of the chicken oviduct hybridized with antisense or sense chicken A2M cRNA probes revealed that A2M mRNA is most abundant in the glandular epithelium (GE) of the magnum, and lesser abundant in GE of the isthmus and luminal epithelium (LE) and GE of the shell gland. Legend: LE, luminal epithelium; GE, glandular epithelium; Scale bar represents 200 μm (the first columnar panels) and 50 μm (the second columnar panels).
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Differential expression of A2M mRNA in normal and cancerous ovaries of hens (study three)
It was next determined if A2M is a biomarker of ovarian cancer in laying hens which is the only animal model that spontaneously develops epithelia-derived ovarian cancer at a high rate as occurs in women [42] . As illustrated in Figure 5B , RT-PCR analyses indicated that A2M mRNA expression was abundant in endometrioid In situ hybridization analyses of A2M mRNA in oviducts of DES-treated and control chicks. In situ hybridization with crosssections of the infundibulum, magnum, isthmus, and shell gland of the chicken oviduct with antisense or sense chicken A2M cRNA probes revealed abundant expression of A2M mRNA only in glandular epithelium (GE) of isthmus and lower expression in GE of the magnum of chick oviducts treated with DES. Legend: LE, luminal epithelium; GE, glandular epithelium; Scale bar represents 200 μm (the first horizontal panels) and 50 μm (the second horizontal panels). carcinomas (lane 2, -3, -6, and -7), which is characterized by glandular patterns resembling those of the endometrium, but there was little or no expression of A2M in serous, mucinous or clear cell carcinomas and normal ovaries (please see Additional file 3, Supplemental Figure S3) . Further, in situ hybridization analysis revealed abundant A2M mRNA localized predominantly to GE of cancerous ovaries, but not LE, stroma or blood vessels ( Figure 6 ).
Discussion
Results of the present study are the first to demonstrate tissue-and cell-specific expression of A2M mRNA in oviducts from normal chickens and to identify high levels of expression of A2M gene in cancerous ovaries of laying hens. Expression of A2M mRNA is unique to the chicken oviduct. In humans, A2M is synthesized primarily in the liver [43, 44] and as a major plasma protein, it makes up roughly 8-10% of the total protein in human blood [45, 46] . However, in chickens, A2M (also known as ovomacroglobulin or ovostatin) is synthesized in the oviduct and found in egg whites [14, 47, 48] . Indeed, the magnum segment of the chicken oviduct synthesizes and secretes components of egg-white such as ovalbumin, conalbumin, lysozyme, and ovomucoid [49] and the isthmus is the site of formation of the soft shell membrane. As illustrated in Figure 2 , A2M mRNA was most abundant in GE of the magnum and isthmus, but also expressed to a lesser extent in both LE and GE of the shell gland. Given the high level of expression of A2M in these two segments of the oviduct, A2M may interact with other proteases to maintain a balance of proteases and protease inhibitors involved in egg formation after ovulation.
It is well known that estrogen is required for normal development of reproductive organs in female mammals and birds [36] . In general, the biological actions of estrogen are mediated by its cognate receptors, estrogen receptors alpha and beta which activate and recruit a variety of transcription factors that bind to estrogen response elements in the 5' upstream region of target genes [16, 17] . Indeed, several steroid hormones, including estrogen, are involved in many physiological and developmental events requiring modification of cell-type and tissue-specific gene expression [16, 32] . Consistent with these results, we reported that exogenous DES affects growth, development and differentiation of the chicken oviduct [35] and discovered candidate genes and pathways regulating oviduct development in chickens [30] . In this study, DES induced A2M mRNA in GE of the infundibulum, magnum, and isthmus of the chick oviduct. These results indicate that A2M is likely regulated by estrogen in the oviduct and that it is likely involved in growth, differentiation and function of the chicken oviduct.
Ovarian cancer is the most lethal gynecological malignancy and the leading cause of cancer-related deaths among woman [50] [51] [52] , but it is rarely diagnosed at an early stage [53] . Therefore, over 75% of woman diagnosed are at an advanced stage of the disease because it is generally asymptomatic [54] and there is no specific biomarker(s) for early detection [38, 55] . Although genetically manipulated rodent models have been used to elucidate some aspects of the etiologies and pathogenesis of ovarian cancer, the non-spontaneous feature of their ovarian cancer limits its clinical application [38, 56, 57] . Meanwhile, the laying hen is a unique animal model for research on human ovarian cancer, because laying hens spontaneously develop epithelial cell-derived ovarian cancer as occurs in women [38, 42, 58] . We found that lysosomal cysteine cathepsin B (CTSB) [59] and serpin peptidase inhibitor, clade B, member 11 (SERPINB11) (unpublished data) are highly expressed in cancerous ovaries of hens. In the present study, as for SERPINB11, A2M is predominantly localized in endometrioid carcinoma, but there was little or no expression in serous, mucinous or clear cell carcinomas and normal ovaries ( Figure 5A and-5B ). In addition, A2M mRNA is abundant in GE of cancerous ovaries, but not in LE, stroma or blood vessels. These results strongly support the idea that proteases and their inhibitors play fundamental roles in a wide variety of biological events including cancer progression and metastasis due to their capacity to degrade extracellular matrix proteins [60] . Although human A2M is a well known major cytotoxic factor in serum which inhibits the DNA synthesis in mouse ovarian tumor cells [61, 62] , Hawkridge and coworkers [63] reported that A2M increased in plasma In situ hybridization analyses of A2M mRNA in normal and cancerous ovaries of hens. Cross-sections of normal and cancerous ovaries of hens hybridized with antisense or sense chicken A2M cRNA probes demonstrated abundant A2M mRNA predominantly in GE of cancerous ovaries, but not in LE, stroma or blood vessels. Legend: F, follicle; GE, glandular epithelium; S, stroma; Scale bar represents 200 μm (the first horizontal panels and sense) or 50 μm (the second horizontal panels and sense).
Lim et al. Reproductive Biology and Endocrinology 2011, 9:137 http://www.rbej.com/content/9/1/137 over a 6 month period in laying hens with late-stage epithelial ovarian cancer. This result provides proteinlevel evidence for up-regulation of a predicted form of A2M in plasma of laying hens that developed Stage IV ovarian cancer as compared to concentrations in plasma of healthy control laying hens. Collectively, our current results indicate that A2M is likely involved in gland morphogenesis and angiogenesis in chicken carcinogenesis. Alternatively, it is possible that A2M interacts reciprocally with other proteases in cancerous ovaries of chickens as it exhibits some inhibitory activity against a variety of proteinases (including serine-, cysteine-, aspartic-and metalloproteinases) [64] .
Results of the present study indicate that A2M is a novel estrogen-regulated gene during development of the chicken oviduct and that it is likely a critical regulator of growth and developmental aspects of epithelial cells of the ovaries of laying hens as they transition from normal to a cancerous state. These results also provide a roadmap for our future research to investigate the precise role(s) of A2M in underlying mechanisms responsible for estrogen-mediated development of the chicken oviduct and as a biomarker to assess the effectiveness of therapies for endometrioid-type ovarian cancer in laying hens.
Additional material
Additional file 1: Supplemental Figure S1 . Multiple sequence alignment of chicken, mammalian and amphibian A2M proteins. (A) The protein sequences of A2M from chicken (Gallus gallus), human (Homo sapiens), chimpanzee (Pan troglodytes), orangutan (Pongo abelii), rhesus monkey (Macaca mulatta), mouse (Mus musculus), rat (Rattus norvegicus), cow (Bos taurus) and frog (Xenopus laevis) were aligned using Geneious Pro Version 5.04 [39] with default penalties for gap and the protein weight matrix of BLOSUM (Blocks Substitution Matrix). Chicken A2M protein has moderate homology to mammalian A2M proteins (42.4-45.4%) and contains the highly conserved MG1 and MG2 domains, the A2M family N-terminal region, and the A2M receptor binding domain found in mammalian A2M. Shaded sequences indicate identical amino acid sequences among all species examined. Dashes represent gaps among the sequences. The conserved functional domains in A2M proteins were identified using the Pfam-A family matrix and NCBI conserved domain database. Figure S2 . The phylogenetic tree generated from alignments of primary sequences of chicken, mammalian and amphibian A2M proteins. Results of phylogenetic tree analysis indicated that chicken A2M was between mammalian and amphibian species consistent with the general pattern of molecular evolution in vertebrates. Bootstrap values from 1,000 replicates are shown at the appropriate branches.
Additional file 2: Supplemental
Additional file 3: Supplemental Figure S3 . Histological types of ovarian cancers in chickens used in this study. Briefly, clear cell carcinoma showed vacuolated cells consisting of nuclear atypia. Serous carcinoma was a solid mass of cells with nuclear atypia. Endometrioid carcinoma had many glands and mucinous carcinoma was differentiated around the stromal region. Each image shows two different regions within each type of carcinoma. Legend: Lane 1, clear cell carcinoma; Lane 2, serous/endometrioid/mucinous carcinoma; Lane 3, endometrioid carcinoma; Lane 4, serous carcinoma; Lane 5, endometrioid/mucinous carcinoma; Lane 6, endometrioid carcinoma; Lane 7, endometrioid carcinoma; Lane 8, clear cell carcinoma; Lane 9, serous/mucinous carcinoma; and Lane 10, serous/endometrioid/mucinous carcinoma.
